283 related articles for article (PubMed ID: 34698107)
21. Genome-wide discovery of circulating cell-free DNA methylation biomarkers for colorectal cancer detection.
Fang Q; Yuan Z; Hu H; Zhang W; Wang G; Wang X
Clin Epigenetics; 2023 Jul; 15(1):119. PubMed ID: 37501075
[TBL] [Abstract][Full Text] [Related]
22. The liquid biopsy in the management of colorectal cancer patients: Current applications and future scenarios.
Normanno N; Cervantes A; Ciardiello F; De Luca A; Pinto C
Cancer Treat Rev; 2018 Nov; 70():1-8. PubMed ID: 30053724
[TBL] [Abstract][Full Text] [Related]
23. Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay.
Zhang Y; Wu Q; Xu L; Wang H; Liu X; Li S; Hu T; Liu Y; Peng Q; Chen Z; Wu X; Fan JB
Clin Epigenetics; 2021 Apr; 13(1):90. PubMed ID: 33892797
[TBL] [Abstract][Full Text] [Related]
24. Stage-differentiated ensemble modeling of DNA methylation landscapes uncovers salient biomarkers and prognostic signatures in colorectal cancer progression.
Muthamilselvan S; Raghavendran A; Palaniappan A
PLoS One; 2022; 17(2):e0249151. PubMed ID: 35202405
[TBL] [Abstract][Full Text] [Related]
25. Aberrant methylation of NPY, PENK, and WIF1 as a promising marker for blood-based diagnosis of colorectal cancer.
Roperch JP; Incitti R; Forbin S; Bard F; Mansour H; Mesli F; Baumgaertner I; Brunetti F; Sobhani I
BMC Cancer; 2013 Dec; 13():566. PubMed ID: 24289328
[TBL] [Abstract][Full Text] [Related]
26. Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles.
Yasui K; Toshima T; Inada R; Umeda Y; Yano S; Tanioka H; Nyuya A; Fujiwara T; Yamada T; Naomoto Y; Goel A; Nagasaka T
Mol Cancer; 2024 Jan; 23(1):1. PubMed ID: 38172877
[TBL] [Abstract][Full Text] [Related]
27. Somatic copy number alteration and fragmentation analysis in circulating tumor DNA for cancer screening and treatment monitoring in colorectal cancer patients.
Hallermayr A; Wohlfrom T; Steinke-Lange V; Benet-Pagès A; Scharf F; Heitzer E; Mansmann U; Haberl C; de Wit M; Vogelsang H; Rentsch M; Holinski-Feder E; Pickl JMA
J Hematol Oncol; 2022 Sep; 15(1):125. PubMed ID: 36056434
[TBL] [Abstract][Full Text] [Related]
28. [Characteristics and diagnostic applications of circulating cell-free DNA in colorectal cancer].
Barták BK; Márkus E; Kalmár A; Galamb O; Szigeti K; Nagy ZB; Zsigrai S; Tulassay Z; Dank M; Igaz P; Molnár B
Orv Hetil; 2019 Jul; 160(30):1167-1177. PubMed ID: 31327245
[TBL] [Abstract][Full Text] [Related]
29. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
[TBL] [Abstract][Full Text] [Related]
30. Discovery and validation of tissue-specific DNA methylation as noninvasive diagnostic markers for colorectal cancer.
Li D; Zhang L; Fu J; Huang H; Liu Y; Zhu L; Sun H; Sun S; Zhang D; Tian T; Wang F; Hu F; Peng X; Li G; Zhao L; Zheng T; Wang X; Cui B; Zhao Y
Clin Epigenetics; 2022 Aug; 14(1):102. PubMed ID: 35974349
[TBL] [Abstract][Full Text] [Related]
31. Feasibility of quantifying
Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S
Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717
[TBL] [Abstract][Full Text] [Related]
32. Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning.
Mori Y; Olaru AV; Cheng Y; Agarwal R; Yang J; Luvsanjav D; Yu W; Selaru FM; Hutfless S; Lazarev M; Kwon JH; Brant SR; Marohn MR; Hutcheon DF; Duncan MD; Goel A; Meltzer SJ
Endocr Relat Cancer; 2011 Aug; 18(4):465-78. PubMed ID: 21636702
[TBL] [Abstract][Full Text] [Related]
33. Liquid Biopsy of Methylation Biomarkers in Cell-Free DNA.
Luo H; Wei W; Ye Z; Zheng J; Xu RH
Trends Mol Med; 2021 May; 27(5):482-500. PubMed ID: 33500194
[TBL] [Abstract][Full Text] [Related]
34. Detection of aberrant methylation of HOXA9 and HIC1 through multiplex MethyLight assay in serum DNA for the early detection of epithelial ovarian cancer.
Singh A; Gupta S; Badarukhiya JA; Sachan M
Int J Cancer; 2020 Sep; 147(6):1740-1752. PubMed ID: 32191343
[TBL] [Abstract][Full Text] [Related]
35. Commonality and differences of methylation signatures in the plasma of patients with pancreatic cancer and colorectal cancer.
Melson J; Li Y; Cassinotti E; Melnikov A; Boni L; Ai J; Greenspan M; Mobarhan S; Levenson V; Deng Y
Int J Cancer; 2014 Jun; 134(11):2656-62. PubMed ID: 24288256
[TBL] [Abstract][Full Text] [Related]
36. Deep cfDNA fragment end profiling enables cancer detection.
Zhitnyuk YV; Koval AP; Alferov AA; Shtykova YA; Mamedov IZ; Kushlinskii NE; Chudakov DM; Shcherbo DS
Mol Cancer; 2022 Jan; 21(1):26. PubMed ID: 35062943
[No Abstract] [Full Text] [Related]
37. Circulating tumour cells and cell-free DNA as a prognostic factor in metastatic colorectal cancer: the OMITERC prospective study.
Salvianti F; Gelmini S; Mancini I; Pazzagli M; Pillozzi S; Giommoni E; Brugia M; Di Costanzo F; Galardi F; De Luca F; Castiglione F; Messerini L; Pinzani P; Antonuzzo L
Br J Cancer; 2021 Jul; 125(1):94-100. PubMed ID: 33953347
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation analysis of tumor suppressor genes in liquid biopsy components of early stage NSCLC: a promising tool for early detection.
Markou Α; Londra D; Tserpeli V; Kollias Ι; Tsaroucha E; Vamvakaris I; Potaris K; Pateras I; Kotsakis Α; Georgoulias V; Lianidou Ε
Clin Epigenetics; 2022 May; 14(1):61. PubMed ID: 35538556
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
40. DNA methylation of phosphatase and actin regulator 3 detects colorectal cancer in stool and complements FIT.
Bosch LJ; Oort FA; Neerincx M; Khalid-de Bakker CA; Terhaar sive Droste JS; Melotte V; Jonkers DM; Masclee AA; Mongera S; Grooteclaes M; Louwagie J; van Criekinge W; Coupé VM; Mulder CJ; van Engeland M; Carvalho B; Meijer GA
Cancer Prev Res (Phila); 2012 Mar; 5(3):464-72. PubMed ID: 22135045
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
